Roh, J-L <br/><br/>
2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx.  [electronic resource] 

 -  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology  Aug 2007 
 - 790-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0748-7983 
<br/><br/><label>Standard No.: </label>10.1016/j.ejso.2007.01.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Carcinoma, Squamous Cell--diagnostic imaging<br/>Chemotherapy, Adjuvant<br/>Cohort Studies<br/>Disease-Free Survival<br/>Female<br/>Fluorodeoxyglucose F18<br/>Follow-Up Studies<br/>Forecasting<br/>Humans<br/>Hypopharyngeal Neoplasms--diagnostic imaging<br/>Laryngeal Neoplasms--diagnostic imaging<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Neoplasm Recurrence, Local--prevention & control<br/>Neoplasm Staging<br/>Patient Care Planning<br/>Positron-Emission Tomography<br/>Radiopharmaceuticals<br/>Radiotherapy, Adjuvant<br/>Salvage Therapy<br/>Survival Rate<br/>Treatment Outcome